Cargando…

Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42

β‐amyloid 1‐42 (Aβ1‐42) is a self‐assembling peptide that goes through many conformational and morphological changes before forming the fibrils that are deposited in extracellular plaques characteristic of Alzheimer's disease. The link between Aβ1‐42 structure and toxicity is of major interest,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vadukul, Devkee M., Gbajumo, Oyinkansola, Marshall, Karen E., Serpell, Louise C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363225/
https://www.ncbi.nlm.nih.gov/pubmed/28185264
http://dx.doi.org/10.1002/1873-3468.12590
_version_ 1782517127431847936
author Vadukul, Devkee M.
Gbajumo, Oyinkansola
Marshall, Karen E.
Serpell, Louise C.
author_facet Vadukul, Devkee M.
Gbajumo, Oyinkansola
Marshall, Karen E.
Serpell, Louise C.
author_sort Vadukul, Devkee M.
collection PubMed
description β‐amyloid 1‐42 (Aβ1‐42) is a self‐assembling peptide that goes through many conformational and morphological changes before forming the fibrils that are deposited in extracellular plaques characteristic of Alzheimer's disease. The link between Aβ1‐42 structure and toxicity is of major interest, in particular, the neurotoxic potential of oligomeric species. Many studies utilise reversed (Aβ42‐1) and scrambled (AβS) forms of amyloid‐β as control peptides. Here, using circular dichroism, thioflavin T fluorescence and transmission electron microscopy, we reveal that both control peptides self‐assemble to form fibres within 24 h. However, oligomeric Aβ reduces cell survival of hippocampal neurons, while Aβ42‐1 and Aβs have reduced effect on cellular health, which may arise from their ability to assemble rapidly to form protofibrils and fibrils.
format Online
Article
Text
id pubmed-5363225
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53632252017-04-06 Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42 Vadukul, Devkee M. Gbajumo, Oyinkansola Marshall, Karen E. Serpell, Louise C. FEBS Lett Communication β‐amyloid 1‐42 (Aβ1‐42) is a self‐assembling peptide that goes through many conformational and morphological changes before forming the fibrils that are deposited in extracellular plaques characteristic of Alzheimer's disease. The link between Aβ1‐42 structure and toxicity is of major interest, in particular, the neurotoxic potential of oligomeric species. Many studies utilise reversed (Aβ42‐1) and scrambled (AβS) forms of amyloid‐β as control peptides. Here, using circular dichroism, thioflavin T fluorescence and transmission electron microscopy, we reveal that both control peptides self‐assemble to form fibres within 24 h. However, oligomeric Aβ reduces cell survival of hippocampal neurons, while Aβ42‐1 and Aβs have reduced effect on cellular health, which may arise from their ability to assemble rapidly to form protofibrils and fibrils. John Wiley and Sons Inc. 2017-02-28 2017-03 /pmc/articles/PMC5363225/ /pubmed/28185264 http://dx.doi.org/10.1002/1873-3468.12590 Text en © 2017 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Communication
Vadukul, Devkee M.
Gbajumo, Oyinkansola
Marshall, Karen E.
Serpell, Louise C.
Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
title Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
title_full Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
title_fullStr Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
title_full_unstemmed Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
title_short Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
title_sort amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid‐β 1‐42
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363225/
https://www.ncbi.nlm.nih.gov/pubmed/28185264
http://dx.doi.org/10.1002/1873-3468.12590
work_keys_str_mv AT vadukuldevkeem amyloidogenicityandtoxicityofthereverseandscrambledvariantsofamyloidb142
AT gbajumooyinkansola amyloidogenicityandtoxicityofthereverseandscrambledvariantsofamyloidb142
AT marshallkarene amyloidogenicityandtoxicityofthereverseandscrambledvariantsofamyloidb142
AT serpelllouisec amyloidogenicityandtoxicityofthereverseandscrambledvariantsofamyloidb142